This site is intended for healthcare professionals
News

SOBI acquires rights outside China to SEL 212 a proposed treatment for gout from Selecta Biosciences

Read time: 1 mins
Last updated:15th Jun 2020
Published:14th Jun 2020
Condition: Gout
Type: drug
Register free for full access to medthority.com